Clinical Trials Update: May 10, 2005
Healthy Patient Studies Ovarian Cancer Brain Metastases
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Healthy Patient Studies
The Substance Use Research Center at Columbia University seeks healthy marijuana smokers (age 21-45) to participate in residential studies evaluating marijuana effects. Live on a research unit at the NYS Psychiatric Institute for 23-25 days. You can earn approximately $1660. Research site located in New York, NY.
UVa Health System Cancer Center seeks adult women with ovarian cancer to test whether an investigational ovarian cancer vaccine developed by the UVa Human Immune Therapy Center is effective. You may be eligible for this trial if you have Stage 3 or 4 ovarian cancer. Research site located in Charlottesville, Va.
EFAPROXYN is a radiation sensitizer that has shown positive results in a Phase 3, randomized clinical trial of patients with brain metastases. Patients will need to return for four follow-up visits within six months after completion of treatment. Adult women with brain metastases from breast cancer may be eligible. Research sites located throughout the United States.
Copyright 2005 CenterWatch. All rights reserved.